(MENAFN- EIN Presswire) CRISPR Technology Market
The CRISPR Technology Market is expected to value USD 900.21 million in 2021 and is projected to grow at a CAGR of 23.8 % during the forecast period.
PUNE, MAHARASHTRA, INDIA, November 30, 2022 /einpresswire.com / -- The crispr technology market research report improves the decision-making capabilities and further helps in creating potent counter-strategies for obtaining competitive advantages as per the recent research report at the Quince Market Insights. The CRISPR Technology market research report is specifically offered for the global market that includes development trends, competitive landscape analysis, and important regions, and development status.
The CRISPR Technology Market is expected to value USD 900.21 million in 2021 and is projected to grow at a CAGR of 23.8 % during the forecast period. Clustered regularly interspaced short palindromic repeats (CRISPR) is a new technology, which helps in finding a specific bit of DNA inside a cell. CRISPR technology has the potential to revolutionize medicine, enabling enhanced disease treatment and diseases prevention.
Request for Sample PDF to Understand More About the Market Outlook and Future Perspectives:
Competitive Landscape
The market research report deals with the in-depth competitive analysis which includes company profiles of the key market players that are operating in the global market. The section also contains information related to the new product launches, mergers, acquisitions, collaborations, etc., to give a clear understanding about the competitive landscape prevailing in the global market. With an emphasis on strategies there have been several primary developments done by major companies such as Thermo Fisher Scientific, Merck KGaA, GenScript, Integrated DNA Technologies (IDT), Horizon Discovery Group, Agilent Technologies, Cellecta, Inc., GeneCopoeia, Inc., New England Biolabs, Origene Technologies, Inc., Synthego Corporation, Toolgen, Inc.
Recent Developments in the Global CRISPR Technology Market
⦿ March 2021 - Scientists at UC San Francisco, UC Berkeley and UCLA have gained U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy. The therapy is for patients with sickle cell disease using the patient's own blood-forming stem cells.
⦿ April 2021 - Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced that the companies have amended their collaboration agreement to develop, manufacture and commercialize CTX001. It is an investigational CRISPR/Cas9-based gene editing therapy. It is being developed as a potentially curative therapy for transfusion-dependent beta-thalassemia (TDT) and sickle cell disease (SCD).
⦿ June 2021 - QIAGEN announced the launch of CRISPR Kit and CRISPR Q-Primer Solutions that allow researchers to analyze edited genetic material with unparalleled speed and efficiency. It will determine how their interventions have changed the function of the DNA sequence in question.
⦿ March 2021 - Sanatech Seed launched the first direct consumption genome-edited tomato in Japan. The Japanese ministries in-charge has announced their determination that the genome-edited tomato will not be regulated as a genetically modified product.
⦿ June 2021 - Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. announced positive interim data of their lead in-vivo genome editing candidate, NTLA-2001 from an ongoing Phase 1 clinical study. It is being developed as a single-dose treatment for transthyretin (ATTR) amyloidosis.
⦿ June 2021 - PerkinElmer and Qiagen are the latest medtechs to target the rapidly growing CRISPR market with technologies designed to aid gene editing to correct genetic defects and treat cancer, hemophilia, sickle cell anemia and other diseases.
Market Segmentation
The market segmentation of the global CRISPR Technology market has been done based on technology, product, distribution channel application, vertical industry, and end-user. Apart from this, the segmentation is also being done based on the geographical landscape. The detailed segmentation offered in the report will help customers get a clear idea about the market segments and the factors that will drive segmental growth. The CRISPR Technology market has been segmented Product and Service (Products {Design Tools, Plasmid and Vector, Cas9 and G-RNA, Delivery System Products}, Services), Applications (Biomedical Applications, Agricultural Applications, Industrial Applications), Technology (Genome Editing/Genetic Engineering, Genetically Modified Organisms, Agricultural Biotechnology, Others), End Users (Pharmaceutical and Biopharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations)
CRISPR Technology Market is further classified on the basis of region as follows:
➣ North America (US, Canada, Mexico)
➣ Europe (Germany, Russia, UK, France, Italy, Spain, The Netherlands, Rest of Europe)
➣ Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Rest of Asia Pacific)
➣ Middle East and Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa)
➣ South America (Brazil, Argentina, Colombia, Rest of South America)
Important Point Covered in the Report:
📌 Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, CRISPR Technology market segments, study objectives, and years considered.
📌 Market Landscape: The competition in the Global CRISPR Technology Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
📌 Companies Profiles: The global CRISPR Technology market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
📌 Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
📌 Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the CRISPR Technology Market.
📌 Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
📌 Research Findings: This section of the report showcases the findings and analysis of the report.
📌 Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Ask For Customization:
Our Report Consists of the Following:
» The latest report for 2022 includes all introductions, overviews and in-depth industry analysis and forecast till 2032.
» Impact analysis of the before and after COVID-19 pandemic outbreak is included in the package as well as Russia Ukraine war impact also.
» Over 500+ pages of research reports (including the latest research)
» Provides detailed chapter-by-chapter instructions on the application
» Updated regional analysis with graphical representations of size, shares and trends in 2022.
» Includes updated tables and figures.
» The latest version of the report includes top market players, their business strategies, sales volume and revenue analysis.
The Research Report Offers Answers to the Following Questions:
1)What is the expected growth rate of the global market for the forecast period?
2)What are the key driving factors that are responsible to shape the fate of the CRISPR Technology market during the forecast period?
3)What will be the overall size of the market during the analysis period?
4)What are the prominent market trends which influence the development of the CRISPR Technology market across various regions?
5)Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
6)What are the challenges and threats that are likely to act as a barrier to the growth of the CRISPR Technology market?
7)What are the major opportunities that the companies can get to attain success in the world?
Have Any Questions Regarding this Market Report, Ask Our Experts: Jemim Haque
Quince Market Insights
+1 208-405-2835
MENAFN30112022003118003196ID1105248733
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.